Download presentation
Presentation is loading. Please wait.
Published byLorin Simpson Modified over 6 years ago
1
Physiological basis of platelet rich plasma therapy
Dr. Raj Selvaratnam School of Medical Sciences University of Auckland
2
PLATELETS
3
PLATELET PRIMARY FUNCTION
4
ADHESION Prevented by nitric oxide & PGl2
Anchored to collagen by von Willebrand factor (VWF)
5
ACTIVATION Inhibited by ADPase & PGl2 released by endothelium
low Ca2+ via cAMP activated pump in platelets PGl2 decreases Ca2+ by increasing cAMP ADP increases Ca2+ decreasing cAMP ADP increases Ca2+ increasing IP3 Calcium induces platelet activation
6
COLLAGEN TRIGGER Binding with platelets activates PLC system
Increases Ca2+ Increases production of Thromboxane2 Decreases PGl2 Via PLA, COX1 & TXA synthase Initiate aggregation
7
GRANULES a, d, g & l granules secrete their content when activated
a granules contain growth factors d granules contain ADP or ATP, Adenosine, Calcium, Serotonin and Histamine
8
a-GRANULES
9
d-GRANULES
10
d-GRANULES Adenosine Serotonin Histamine ATP & ADP
Acts on Macrophages to produce pro- and anti- inflammatory effects acting via cytokines Serotonin Increases capillary permeability and interacts with Macrophages Histamine Increases perfusion via dilation and permeability. Strong activator of Macrophages ATP & ADP Promotes Platelet activation and aggregation
11
PDGF in muscle healing Myoblast have PDGF receptors
In humans mainly the b-isoform Activation increases DNA synthesis Cell density Leads to muscle development & regeneration
12
TGF-b in muscle healing
Inhibits muscle differentiation Down-regulates RNA Interacts with PDGF to increase cell density and retain muscle type
13
IGF in muscle healing Increases Muscle mass and strength
Satellite cell activation Increases protein synthesis
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.